MdxHealth

Beleggen, aandelen kopen in België, informatie, koersen en analyses
Gebruikersavatar
Banner
Premiummember
Premiummember
Berichten: 1964
Lid geworden op: 19 feb 2015 09:29
waarderingen: 1159
Contacteer:

Re: MdxHealth

Bericht door Banner »

Press release Regulated information 28 May 2020, 11:00 p.m. CEST

IRVINE, CA, and HERSTAL, BELGIUM – 28 May 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage innovative molecular diagnostics company, today held its annual general shareholders' meeting ("AGM") and an extraordinary general shareholders' meeting ("EGM").

The items on the agenda of the AGM included the approval of a number of resolutions relating to the financial year ended on 31 December 2019. There was no attendance quorum for the AGM, and the proposed resolutions that were submitted to meeting were all duly passed.

As the required attendance quorum for the EGM was not met, a new EGM will be held on 30 July 2020 (unless decided otherwise by the Company). There will be no attendance quorum for this second EGM.

Exceptionally, and in accordance with the Belgian Royal Decree no. 4 of 9 April 2020 on miscellaneous provisions relating to co-ownership and corporate and association law in the context of the fight against the COVID-19 pandemic, the AGM and EGM were held behind closed doors without the physical presence of the holders of securities of the Company and their representatives.

The minutes of the AGM and documents that were submitted to the meetings can be accessed via the Company’s website.

About MDxHealth®
MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:
MDxHealth
info@mdxhealth.com

Important information

The MDxHealth logo, MDxHealth, ConfirmMDx and SelectMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the Company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation.

Attachment

This messsage was distributed by Nasdaq's GlobeNewswire.
(165 Broadway, New York, NY, 10006, USA, 1.212.401.8700, www.nasdaq.com)
On behalf of MDxHealth (R) Cap Business Center rue D'abhooz 31, Herstal, 4040 BE
wolfe liked last!





Volg Beursig.com op Twitter en Facebook

     


Gebruikersavatar
MGiles
Forum actieveling
Forum actieveling
Berichten: 321
Lid geworden op: 20 mar 2018 17:31
waarderingen: 80
Contacteer:

Re: MdxHealth

Bericht door MGiles »

Hey,

Het is al een tijdje geleden dat ik dit bedrijf heb opgevolgd. Ben verbaasd dat het nog niet failliet is. :D
Heeft dit nog toekomst of is het een uitdovend verhaal?
Geduld is een schone deugd

wolfe
Forum actieveling
Forum actieveling
Berichten: 275
Lid geworden op: 28 feb 2013 10:52
waarderingen: 197
Contacteer:

Re: MdxHealth

Bericht door wolfe »

Scorpiaux BVBA notified MDxHealth that the aggregate number of shares with respect to which Scorpiaux BVBA can exercise voting rights passively crossed below the threshold of 5% of the outstanding shares and voting rights of MDxHealth. Notably, it follows from the notification by Scorpiaux BVBA that it owns 3,867,776 shares of MDxHealth, representing 4.26% of the 90,691,449 outstanding shares and voting rights of MDxHealth. The notification states that Scorpiaux BVBA is exclusively controlled by Bart Versluys.
Wimpie85 liked last!

Gebruikersavatar
Banner
Premiummember
Premiummember
Berichten: 1964
Lid geworden op: 19 feb 2015 09:29
waarderingen: 1159
Contacteer:

Re: MdxHealth

Bericht door Banner »

Press release Regulated information 4 June 2020, 11 p.m. CEST

IRVINE, CA, and HERSTAL, BELGIUM – 4 June 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage innovative molecular diagnostics company, announces today in accordance with Article 14 of the Belgian Act of 2 May 2007 on the disclosure of important participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions (the "Belgian Transparency Act"), that on 2 June 2020 it received the following notification of significant shareholdings as a consequence of the capital increase completed on 15 May 2020.

Scorpiaux BVBA notified MDxHealth that the aggregate number of shares with respect to which Scorpiaux BVBA can exercise voting rights passively crossed below the threshold of 5% of the outstanding shares and voting rights of MDxHealth. Notably, it follows from the notification by Scorpiaux BVBA that it owns 3,867,776 shares of MDxHealth, representing 4.26% of the 90,691,449 outstanding shares and voting rights of MDxHealth. The notification states that Scorpiaux BVBA is exclusively controlled by Bart Versluys.

For further information, reference is made to the information published on MDxHealth's website (http://www.mdxhealth.com/investors/shar ... nformation).

Pursuant to the Belgian Transparency Act and the articles of association of the Company, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.

About MDxHealth®
MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:
MDxHealth
info@mdxhealth.com

Important information

The MDxHealth logo, MDxHealth, ConfirmMDx and SelectMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

This messsage was distributed by Nasdaq's GlobeNewswire.
(165 Broadway, New York, NY, 10006, USA, 1.212.401.8700, www.nasdaq.com)
On behalf of MDxHealth (R) Cap Business Center rue D'abhooz 31, Herstal, 4040 BE

Gebruikersavatar
a21
Forum elite
Forum elite
Berichten: 5128
Lid geworden op: 17 nov 2012 12:19
waarderingen: 4595
Contacteer:

Re: MdxHealth

Bericht door a21 »

MDxHealth roept op tot extra aandeelhoudersvergadering
Gepubliceerd op 30 juni 2020 07:43 |

(ABM FN) MDxHealth heeft zijn aandeelhouders bijeengeroepen voor een buitengewone vergadering op 30 juli. Dit maakte het diagnosticabedrijf dinsdag voorbeurs bekend.

Op de agenda staan een aantal nieuwe benoemingen en het beloningsbeleid.

Ook wordt er door de board opnieuw toestemming gevraagd om nieuwe aandelen te mogen uitgeven.

Vanwege de coronacrisis is de vergadering niet fysiek toegankelijk. Aandeelhouders moeten op voorhand aangeven hoe zij willen stemmen. Dit dient bij voorkeur per email te gebeuren. Ook vragen kunnen op die wijze worden ingediend.
Wimpie85 liked last!

Gebruikersavatar
MGiles
Forum actieveling
Forum actieveling
Berichten: 321
Lid geworden op: 20 mar 2018 17:31
waarderingen: 80
Contacteer:

Re: MdxHealth

Bericht door MGiles »

Lijkt een verhaaltje zonder einde. Hebben ze al niet 3 jaar een werkend product dat ze gewoon niet verkocht krijgen?
Geduld is een schone deugd

El Dinero
Forum gebruiker
Forum gebruiker
Berichten: 158
Lid geworden op: 04 apr 2014 08:33
waarderingen: 35
Contacteer:

Re: MdxHealth

Bericht door El Dinero »

Momenteel moet je dit aandeel vooral aankopen voor de korte termijn, je kan er zo wel wat winst uit halen.
Volgens TA is het klaar om uit het kanaal 0.70-0.73 te breken richting 0.80.
De biedzijde is goed gevuld, ik ga ook instappen en dan afwachten tot de volgende resultaten.

Deelnemen aan het forum + meer functies?

Discussieer met duizenden beleggers, minder
advertenties, ideaal voor smartphone, betere
gebruikservaring en gratis abonneren op favoriete
onderwerpen. Registreer binnen 1 minuut!


Plaats reactie